Catherine Brahic, Marina Lemle and Sophie Hebden
No image available
/ 6 June 2006

World needs renewed focus on ‘neglected diseases’

Medicines to treat common diseases in poorer countries tend to be old and are often ineffective. But the pharmaceutical industry has little incentive to research new drugs: patients in developing countries can’t afford them. All that may change, as ”needs-driven” research on diseases that afflict developing countries gathers momentum.